Where are persons with intellectual disabilities in medical research? A survey of published clinical trials

Journal of Intellectual Disability Research

Volumn 58, Issue 9, 2014, Pages 800-809

  Feldman, M A ^a   Bosett, J ^a   Collet, C ^a   Burnham Riosa, P ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

Ethics; Inclusion; Intellectual disabilities; Medical research

Indexed keywords

ARTICLE; COGNITION; DECISION MAKING; FOLLOW UP; HUMAN; INTELLECTUAL IMPAIRMENT; MEDICAL RESEARCH; POLICY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VULNERABLE POPULATION; CLINICAL TRIAL (TOPIC); META ANALYSIS; PATIENT SELECTION; STANDARDS;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; INTELLECTUAL DISABILITY; PATIENT SELECTION;

EID: 84905567827     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/jir.12091     Document Type: Article

References (44)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text rev. American Psychiatric Association, Washington, DC.
2. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada & Social Sciences and Humanities Research Council of Canada (December 2010). Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. Available at: http://www.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf (retrieved 7 April 2013).
3. Charlton J. (1998) Nothing about Us without Us: Disability Oppression and Empowerment. University of California Press, Berkeley, CA.
4. Cleaver S., Ouellette-Kuntz H. & Sakar A. (2010) Participation in intellectual disability research: a review of 20 years of studies. Journal of Intellectual Disability Research 54, 187-193.
5. Cook D., Moore-Cox A., Xavier D., Lauzier F. & Roberts I. (2008) Randomized trials in vulnerable populations. Clinical Trials 5, 61-69. doi:10.1177/1740774507087552.
6. Cortina-Borja M., Tan H. K., Wallon M., Paul M., Prusa A., Buffolano W. etal. (2010) Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. Public Library of Science Medicine 7, e1000351. doi:10.1371/journal.pmed.
7. Feldman M. A. & Case L. (1999) Teaching child-care and safety skills to parents with intellectual disabilities via self-learning. Journal of Intellectual and Developmental Disability 24, 27-44.
8. Feldman M. A., Battin S., Shaw O. & Luckasson R. (2012a) Inclusion of children with disabilities in mainstream child development research. Disability and Society. doi:10.1080/09687599.2012.748647.
9. Feldman M. A., Owen F., Andrews A. E., Hamelin J. P., Barber R. & Griffiths D. (2012b) Health self-advocacy training for persons with intellectual disabilities. Journal of Intellectual Disability Research 56 (Part II), 1110-1121. doi:10.1111/j.1365-2788.2012.01626.x.
10. Fisher J. A. & Kalbaugh C. A. (2011) Challenging assumptions about minority participation in US clinical research. American Journal of Public Health 101, 2217-2222.
11. Folstein M. F., Folstein S. E. & McHugh P. R. (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
12. Guttmacher A. E. (April 2011) A vision for the future of child development research. Invited Address presented at the biannual meeting of the Society for Research in Child Development, Montreal, Canada.
13. Iacono T. (2006) Ethical challenges and complexities of including people with intellectual disability as participants in research. Journal of Intellectual and Developmental Disability 31, 173-179.
14. Jenkins D., Jones J., Lamarche P. J., Kendall B., Faulkner C. W., Cermakova D. etal. (2011) Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. Journal of the American Medical Association 306, 831-839. doi:10.1001/jama.2011.1202.
15. Lai R., Elliott D. & Ouellette-Kuntz H. (2006) Attitudes of research ethics committee members toward persons with intellectual disabilities: the need for more research. Journal of Policy and Practice in Intellectual Disabilities 3, 114-118.
16. Lavine J., Schwimmer J., Van Natta M., Molleston J., Murray K., Rosenthal P. etal. (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. Journal of the American Medical Association 305, 1659-1668. doi:10.1001/jama.2011.520.
17. Lennox N., Taylor M., Rey-Conde T., Bain C., Purdie D. M. & Boyle F. (2005) Beating the barriers: recruitment of people with intellectual disability to participate in research. Journal of Intellectual Disability Research 49, 296-305.
18. Lie K. K., Grholt E. & Eskild A. (2010) Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study. British Medical Journal 341, c4990-c4990. doi:10.1136/bmj.c4990.
19. Lunsky Y., Fedoroff P., Klassen K., Gracey C., Havercamp S., Fedoroff B. etal. (2009) Medical rights for people with intellectual disabilities. In: Challenges to the Human Rights of People with Intellectual Disabilities (eds F. A. Owen & D. M. Griffiths ), pp. 155-183. Jessica Kingsley, London.
20. McDonald K. E. (2012) 'We want respect': adults with intellectual and developmental disabilities address respect in research. American Journal on Intellectual and Developmental Disabilities 117, 263-274.
21. McDonald K. E. & Keys C. B. (2008) How the powerful decide: access to research participation by those at the margins. American Journal of Community Psychology 42, 79-93.
22. McDonald K. E. & Kidney C. A. (2012) What is right? Ethics in intellectual disabilities research. Journal of Policy and Practice in Intellectual Disabilities 9, 27-39.
23. Mactavish J., Mahon M. & Lutfiyya L. (2000) 'I can speak for myself': involving individuals with intellectual disabilities as research participants. Mental Retardation 38, 216-227.
24. McVilly K. R. & Dalton A. J. (2006) Commentary on Iacono (2006): 'Ethical challenges and complexities of including people with intellectual disability as participants in research'. Journal of Intellectual and Developmental Disability 31, 186-188.
25. Mason V. L., Shaw B., Wiles N. J., Mulligan J., Peters T. J., Sharp D. etal. (2007) GPs' experiences of primary care mental health research: a qualitative study of the barriers to recruitment. Family Practice 24, 518-525. doi:10.1093/fampra/cmm047.
26. Matson J. L. & Neal D. (2009) Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview. Research in Developmental Disabilities 30, 572-586. doi:10.1016/j.ridd.2008.08.007.
27. Maulik P. K., Mascarenhas M. N., Mathers C. D. & Dua T. (2011) Prevalence of intellectual disability: a meta-analysis of population based studies. Research in Developmental Disabilities 2, 419-436.
28. Monti M., Vanhaudenhuyse A., Coleman M., Boly M., Pickard J., Tshibanda L. etal. (2010) Willful modulation of brain activity in disorders of consciousness. The New England Journal of Medicine 362, 579-589. doi:10.1056/NEJMoa0905370.
29. National Center on Universal Design in Learning (2011) UDL Guidelines - Version 2.0: Research Evidence. Available at: http://www.udlcenter.org/research/researchevidence (retrieved 27 June 2013).
30. National Institutes of Health (NIH) (1979) The Belmont Report: ethical principles and guidelines for the protection of human subjects of research (18 April 1979). Available at: http://www.hhs.gov/ohrp/policy/belmont.html (retrieved 27 June 2013).
31. Office of the United Nations High Commissioner for Human Rights (2006) United Nations convention on the rights of persons with disabilities. Available at: http://www.ohchr.org/english/law/pdf/disabilities-convention.pdf (retrieved 27 June 2013).
32. Oliver-Africano P., Dickens S., Ahmed Z., Bouras N., Cooray S., Deb S. etal. (2010) Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities. Journal of Intellectual Disability Research 54, 17-25. doi:10.1111/j.1365-2788.2009.01195.x.
33. Pinn V. W. (2005) Research on women's health: progress and opportunities. Journal of the American Medical Association 294, 1407-1410. doi:10.1001/jama.294.11.1407.
34. Quest T. & Marco C. A. (2003) Ethics seminars: vulnerable populations in emergency medicine research. Academic Emergency Medicine Journal 10, 1294-1298.
35. Rappolt-Schlichtmann G., Daley S. G. & Rose L. T. (2012) A Research Reader in Universal Design for Learning. Harvard Education Press, Cambridge, MA.
36. Raveendran N. S., Tharyan P., Alexander J. & Adams C. E. (2007) Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. British Medical Journal 335, 865-865. doi:10.1136/bmj.39341.608519.BE.
37. Rochon P. A., Mashari A., Cohen A., Misra A., Laxer D., Streiner D. L. etal. (2004) The inclusion of minority groups in clinical trials: problems of under-representation and under-reporting of data. Accountability in Research 11, 215-223.
38. Snelgrove S. (2005) Bad, mad and sad: developing a methodology of inclusion and a pedagogy for researching students with intellectual disabilities. International Journal of Inclusive Education 9, 313-329.
39. Tyrer P., Oliver-Africano P., Ahmed Z., Bouras N., Cooray S., Deb S. etal. (2008) Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 371, 57-63. doi:10.1016/S0140-6736(08)60072-0.
40. United States Congress (2008) Americans with Disabilities Act of 1990, as amended. Available at: http://www.ada.gov/pubs/adastatute08.pdf (retrieved 27 June 2013).
41. United States Department of Health & Human Services (October 2001) National Institutes of Health Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. Available at: http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm (retrieved 27 June 2013).
42. Williams N., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R. etal. (2010) Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376, 1401-1408. doi:10.1016/S0140-6736(10)61109-9.
43. World Medical Association (1964) Declaration of Helsinki - ethical principles for medical research involving human subjects. Available at: http://www.fda.gov/ohrms/dockets/dockets/06d0331/06D-0331-EC20-Attach-1.pdf (retrieved 27 June 2013).
44. Zulman D. M., Sussman J. B., Chen X., Cigolle C. T., Blaum C. S. & Hayward R. A. (2011) Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized control trials. Journal of General Internal Medicine 26, 783-790. doi:10.1007/s11606-010-1629-x.